These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16314631)

  • 21. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
    Riedl CC; Akhurst T; Larson S; Stanziale SF; Tuorto S; Bhargava A; Hricak H; Klimstra D; Fong Y
    J Nucl Med; 2007 May; 48(5):771-5. PubMed ID: 17475966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
    Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G
    Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography with F-18 fluorodeoxyglucose in evaluating colorectal hepatic metastasis down-staged by chemotherapy.
    Takahashi S; Kuroki Y; Nasu K; Nawano S; Konishi M; Nakagohri T; Gotohda N; Saito N; Kinoshita T
    Anticancer Res; 2006; 26(6C):4705-11. PubMed ID: 17214330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.
    Zubeldia JM; Bednarczyk EM; Baker JG; Nabi HA
    Cancer Biother Radiopharm; 2005 Aug; 20(4):450-6. PubMed ID: 16114993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
    Wildi SM; Gubler C; Hany T; Petrowsky H; Clavien PA; Jochum W; Gerlach T; Fried M; Mullhaupt B
    J Clin Ultrasound; 2008 Jan; 36(1):20-6. PubMed ID: 17937421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases.
    Wiering B; Adang EM; van der Sijp JR; Roumen RM; de Jong KP; Comans EF; Pruim J; Dekker HM; Ruers TJ; Krabbe PF; Oyen WJ
    Nucl Med Commun; 2010 Nov; 31(11):938-44. PubMed ID: 20856152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between therapy response assessment using FDG PET/CT and histopathologic tumor regression grade in hepatic metastasis of colorectal carcinoma after neoadjuvant therapy.
    Burger IA; Schwarz EI; Samarin A; Breitenstein S; Weber A; Hany TF
    Ann Nucl Med; 2013 Feb; 27(2):177-83. PubMed ID: 23233085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent chemotherapy reduces the maximum-standardized uptake value of 18F-fluoro-deoxyglucose positron emission tomography in colorectal cancer.
    Lee M; Yeum TS; Kim JW; Oh S; Lee SA; Moon HR; Choi YH; Han YM; Choi JM; Jang DK
    Gut Liver; 2014 May; 8(3):254-64. PubMed ID: 24827621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
    Bipat S; van Leeuwen MS; Comans EF; Pijl ME; Bossuyt PM; Zwinderman AH; Stoker J
    Radiology; 2005 Oct; 237(1):123-31. PubMed ID: 16100087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
    Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
    J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.
    Truant S; Huglo D; Hebbar M; Ernst O; Steinling M; Pruvot FR
    Br J Surg; 2005 Mar; 92(3):362-9. PubMed ID: 15672427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy. Impact of PET with 18F-fluorodeoxyglucose on therapeutic decisions.
    Amthauer H; Denecke T; Hildebrandt B; Rühl R; Miersch A; Nicolaou A; Ruf J; Plotkin M; Hänninen EL; Stroszczynski C; Gutberlet M; Langrehr J; Riess H; Ricke J
    Nuklearmedizin; 2006; 45(4):177-84. PubMed ID: 16964344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review.
    Patel S; McCall M; Ohinmaa A; Bigam D; Dryden DM
    Ann Surg; 2011 Apr; 253(4):666-71. PubMed ID: 21475005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of FDG-PET in surgical management of patients with colorectal liver metastases.
    Teague BD; Morrison CP; Court FG; Chin VT; Costello SP; Kirkwood ID; Maddern GJ
    ANZ J Surg; 2004 Aug; 74(8):646-52. PubMed ID: 15315564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.
    Piduru SM; Schuster DM; Barron BJ; Dhanasekaran R; Lawson DH; Kim HS
    J Vasc Interv Radiol; 2012 Jul; 23(7):943-8. PubMed ID: 22609292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.